drugset / Trial / NCT02253862
Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers
NaSingle-groupOpen-labelTreatment
Summary
Study to assess the effects of single-dose and steady-state tipranavir/ritonavir 500 mg/200 mg on the single-dose pharmacokinetics of tadalafil 10 mg
Timeline
- Start
- 2005-12
- Primary completion
- 2006-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritonavir | Other / unclassified | 200 mg | — |
| Subject | Tadalafil | Small molecule | 10 mg | Oral |
| Subject | Tipranavir | Small molecule | 500 mg | — |
Indications
No indication recorded.